Advertisement Pharmaceutical Business review - Page 1621 of 5283 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 23, 2026

Evogene and ELEO to develop new oral PCSK9 inhibitors

Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.

Continue
The companies intend to identify and advance differentiated oral small molecules that could offer alternatives in the expanding market. Credit: Wasan Tita/Shutterstock.com.
July 23, 2026

Affinia Therapeutics receives FDA orphan drug designation for AFTX-201

AFTX-201 uses a functional BAG3 transgene and Affinia’s proprietary capsid for targeted, lower-dose heart delivery. Credit: Umaporn Kensila/Shutterstock.com.
July 22, 2026

Kyowa Kirin EMEA’s Crysvita approved by EC for infants with XLH

The trial assessed burosumab in paediatric patients from birth to one year. Credit: Inara Prusakova / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Cellares and Papillon partner for PPL-001 manufacturing automation
  2. EMA’s CHMP grants PRIME status to AbelZeta’s C-CAR168
  3. Halozyme and Incyte sign licence agreement for INCA033989 formulations
  4. Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal
  5. Aptar unveils framework for injectable drug delivery systems

PRESS RELEASES

SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography